Insecticidal water-in-oil (w / o) formulation
Patent Information
- Application Number
- LAP331
- Authority / Receiving Office
- LA · LA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2012-05-16
- Filing Date
- 2013-05-14
- Publication Date
- 2024-03-01
AI Technical Summary
Existing insecticidal water-in-oil (W/O) formulations are not physicochemically stable and cannot be used in a one-step process to treat carrier materials like paper, as they suffer from coalescence and creaming issues, and fail to combine insecticidal active ingredients with burnt salts effectively.
A W/O formulation comprising a surface-active emulsifying system with low solubility in potassium nitrate salt solutions, non-aqueous solvents, burnt salts, and insecticidal active ingredients, ensuring stability and suitability for one-step treatment of carrier materials.
The formulation provides a stable, homogeneous distribution of active ingredients on carrier materials, enabling cost-effective and industrially robust one-step treatment, maintaining physical stability during application and ensuring effective insecticidal performance.
Smart Images

Figure 00000000_0000_ABST
Abstract
Description
[0001] Insecticidal water-in-oil (W / O) formulation
[0002] The invention relates to an insecticidal water-in-oil (W / O) formulation comprising at least one insecticidal active ingredient and at least one scorching salt, and to the preparation of this formulation. The formulation according to the invention is particularly suitable for treating suitable carrier materials, especially paper carriers, in a cost-effective, one-step process using conventional application methods. Furthermore, the present invention relates to insecticidal, smoldering products that can be produced by treating a carrier material with the formulation according to the invention.
[0003] US-A-2009 / 0163582 describes a water-in-oil (W / O) formulation in which a polyglycerol fatty acid ester or a sorbitan fatty acid ester is used as the emulsifier, a pesticide (e.g., a pyrethroid) as the active ingredient, and acetyl esters, methyl esters, acetyl tributyl citrate, white mineral oil, or a combination thereof as the solvent. This formulation is an end-user aerosol formulation.
[0004] WO-A-2007 / 131679 describes paper impregnated with an insecticidal active ingredient. The paper is produced in a two-step process in which it is first pretreated with a 6% aqueous potassium nitrate solution, then dried, and finally impregnated with an active ingredient solution in a further step. WO-A-2007 / 131679 does not disclose a formulation in which the paper can be treated in a one-step process, particularly with an insecticidal active ingredient and the potassium nitrate salt.
[0005] WO-A-201 1 / 092722 describes a paper impregnated with a insecticidal active ingredient, which is also produced using a two-step process. Analogous to the process described in WO-A-2007 / 131679, the paper is first treated with potassium nitrate before being impregnated with the active ingredient after drying.
[0006] The object of the present invention was to provide a formulation that is physicochemically stable in the presence of an insecticidal active ingredient (i.e., a pyrethroid) and a pyrolytic agent, and is particularly suitable for treating a substrate such as paper. The formulation should preferably enable the substrate to be treated in a cost-effective and industrially robust one-step process. In this one-step process, the required application weight of the formulation according to the invention is applied to the substrate in a single process step, so that the substrate subsequently contains the functional formulation components, such as the active ingredient and the pyrolytic agent, in a sufficient and homogeneous distribution. The formulations described in the prior art are not suitable for solving this problem. In particular, it is not possible with these known formulations to combine an insecticidal active ingredient together with the required scorching salt in a single formulation and to use it for the purpose of the invention. Specifically, such formulations are not sufficiently stable physicochemically (against coalescence and creaming) and do not possess the rheological properties necessary for the purpose required by the invention, nor can they be readily adapted to conventional machines and methods for applying the formulation to a suitable carrier material.
[0007] Surprisingly, it has now been found that the task can be accomplished by a water-in-oil (W / O) reaction.
[0008] Formulation comprising a) at least one surface-active emulsifying system which has a solubility of less than lg / in a 16% potassium nitrate salt solution ' L contains, b) at least one non-aqueous solvent, c) at least one fire salt, d) at least one insecticidal active ingredient, and e) water.
[0009] A water-in-oil (W / O) formulation generally describes a multiphase system in which an aqueous phase is dispersed within a continuous oil phase. In this context, the term "oil" is a broad term encompassing water-insoluble liquids and solvents that cause phase separation when mixed with water or aqueous salt solutions. Examples include aliphatic and aromatic solvents, vegetable and animal oils and their derivatives, fragrances, or mixtures thereof.
[0010] Experimentally, a water-in-oil (W / O) and an oil-in-water (O / W) formulation are differentiated by determining the specific conductivity. Aqueous salt solutions with a salt concentration of 5 wt.% and higher typically have a high specific conductivity in the mS / cm range, while the specific conductivity of aliphatic and aromatic solvents is typically in the LI S / cm range or below. Consequently, a formulation containing sulfuric acid is experimentally classified as a W / O formulation if its specific conductivity is less than 0.1 mS / cm. mS / cm. The conductivity of the present W / O formulation according to the invention is therefore preferably less than 0.1 mS / cm, measured at room temperature (20°C).
[0011] At least one surface-active emulsifying system suitable for the W / O formulations according to the invention are surface-active emulsifiers which each have a solubility (where the solubility is measured using conventional methods at a temperature of 20°C) of less than lg / 'L.
[0012] Suitable surface-active emulsifying systems that exhibit a solubility of less than lg / L in a 16% potassium nitrate salt solution are preferably nonionic surface-active emulsifiers (also referred to as nonionic surface-active agents) with an IIL B value in the range of about 2 to about 10, preferably 2 to 10, more preferably between about 2 and about 8, and particularly preferably between about 3 and about 6, preferably between 3 and 6. Some of the surface-active agents usable according to the invention are listed, for example, in Kirk-Othmer, "Encyclopedia of Chemical Technology", 3rd ed., 1979, Vol. 8, page 913.
[0013] The HLB value (hydrophilic-lipophilic balance) is an empirical scale defined by WC Griffin (J. Soc. Cosmetic Chemists, 1, 311 (1949)) that expresses the amphiphilic nature of emulsifying agents (especially nonionic surfactants). The least hydrophilic surfactants are assigned the lowest HLB values. Methods for determining the HLB are well known in the field, and any of these methods can be applied to HLB determination. A description of the HLB system and methods for determining the HLB are described in "The HLB System: At a Time Saving Guide to Emulsifier Selection," T. Americas Inc., Wilmington, Delaware, 1976.
[0014] Suitable surfactants according to the invention are particularly preferably selected from the group consisting of alkylphenol ethoxylates, alkanol ethoxylates, alkylamine ethoxylates, sorbitan esters (such as Spans) and their ethoxylates (such as Tweens), castor oil ethoxylates, ethylene oxide / propylene oxide block copolymers, alkanol / propylene oxide / ethylene oxide copolymers, polyglycerols and polyglycerol esters.
[0015] The hydrophilicity / liphophilicity equilibrium (FILB value) of non-ionic surfactants can be adjusted by changing the degree of ethoxylation.
[0016] Examples of non-ionic surfactants suitable for use in W / O formulations for the invention are (listed in order of brand name, HLB value, company): Brij 52 POE-(2)-cetyl alcohol, 5,3; Croda; Brij 72 POE-(2)-stearyl alcohol, 4,9, Croda; Brij 92V POE-(2)-oleyl alcohol, 4,9, Croda; Disponil TA 1, 3, Cognis; Span 20, sorbitan monolaurate, 8,6, Croda; Span 40 sorbitan monopalmitate, 6,7, Croda; Span 60 sorbitan monostearate, 4,7, Croda; Span 80 sorbitan monooleate, 4.3, Croda; Span 85, sorbitan trioleate, 1.8, Croda; Hostacerin SFO, 3-4, Clariant; AGNIQUE® 1 0! I 70C-2 EO (Synative 3370) Cognis; Dehypon (K 502, Cognis; Dehypon
[0017] OCP 503, Cognis; AGNIQUE® FOi l 90C-5, 4.9, Cognis; AGNIQUE® FOi l 90C-3, 6.6, Cognis; AGNIQUE® FOI I 50C-4, 9, Cognis; Genapol O 020, 5, Clariant; Atlox 4912. 5-6; Atlox 4914, 5-7, Emuisogen V 1816, 6, Clariant; Emuisogen V 1816- 1, 8, Clariant; Genapol PF 10, 2, Clariant; Genapol PF 20 P, 4, Clariant; Genapol PF 40, 6, Clariant; Genapol 2822, 6, Clariant; Genapol 3970, 3, Clariant; Agrimer AI 25, 3-5, ISP; Agrimer A I. 23, 9-1 1 , ISP; Agrimer AI. 1 , 7-8 , ISP; Agrimer VA-3, 4-7, ISP; LAMEFORM® TGI, Cognis; Monomuls 90-O 18, Cognis; DEHYMULS® PGP1 I, Cognis; Hostacerin DGI, 5, Clariant; GW 1250 ( HIB 5), 5, Evonik. According to the invention, ionic surfactants are also suitable as surface-active emulsifying systems, which exhibit a solubility in a 16% potassium nitrate salt solution (where the
[0018] (Solubility measured using conventional methods at a temperature of 20°C) is less than lg / L.
[0019] The ionic surfactants for the emulsifying system are preferably selected from the group of anionic surfactants consisting of alkyl sulfonates, aryl sulfonates, alkyl aryl sulfonates, aryl ether sulfonates, lignosulfonates, alkyl sulfates, alkyl ether sulfates, sulfosuccinates, aliphatic and aromatic phosphate esters, alkoxylated phosphate esters, alkyl carboxylates and polycarboxylates; each as salts with monovalent or polyvalent cations (for example, alkali metal salts, alkaline earth metal salts, ammonium salts) or together with a cationic surfactant (such as aliphatic primary, secondary and tertiary amines from the Armeen® series by AkzoNobel).
[0020] Particularly preferred are anionic surfactants for the emulsifying system selected from the group consisting of aliphatic alcohol sulfates, alkylarylsulfonates, or lignosulfonates; each as salts with monovalent or polyvalent cations. Preferably, the anionic surfactants in the formulation according to the invention are each present as metal salts with a polyvalent cation (for example, calcium salt, magnesium salt, aluminum salt, and iron salt).
[0021] Alkaline earth metal salts and, even more preferably, calcium salts are used as salts of polyvalent cations. In a further preferred embodiment of the invention, an emulsifying system is selected for the formulation as at least one emulsifying system for W / O formulations from the group consisting of: alkyl sulfonates, aryl sulfonates, alkyl aryl sulfonates, aryl ether sulfonates, lignosulfonates, alkyl sulfates, alkyl ether sulfates, sulfosuccinates, aliphatic and aromatic phosphate esters, alkoxylated Phosphate esters, alkyl carboxylates and polycarboxylates; each as salts of multivalent cations, preferably alkaline earth metal salts and even more preferably calcium salts, are used.
[0022] Examples of such an emulsifying system include calcium salts of alkylarylsulfonates CALSOGEN® 4814 (Clariant) and NANSA EVM 70 / 2E (Huntsmann), Emulsifier 1371 A (Clariant), and, for example, calcium, magnesium, and aluminum soaps of various fatty acids (such as Liga Calcium Stearate CPR-5, Ligamed MF-2-V, and Ligastar ALG-V from Peter Greven Fett-Chemie GmbH & Co. KG).
[0023] In a further preferred embodiment of the invention, a nonionic surfactant selected from the group consisting of alkylphenol ethoxylates, alkanol ethoxylates, alkylamine ethoxylates, sorbitan esters and their ethoxylates, castor oil ethoxylates, ethylene oxide / propylene oxide block copolymers, alkanol / propylene oxide / ethylene oxide copolymers, polyglycerols, polyglycerol esters, or an emulsifying system selected from the group consisting of alkylsulfonates, arylsulfonates, alkylarylsulfonates, aryl ethersulfonates, lignosulfonates, alkyl sulfates, alkyl ether sulfates, sulfosuccinates, aliphatic and aromatic phosphate esters, alkoxylated phosphate esters, alkylcarboxylates, and polycarboxylates, each as salts of multivalent cations, is used as at least one emulsifying system for W / O formulations.
[0024] In general, the W / O formulation comprises 0.1 to 15 wt.%, preferably 0.5 to 10 wt.%, and even more preferably 1.5 to 5 wt.%, of at least one surfactant emulsifying system, which has a solubility of less than lg / L in a 16% potassium nitrate salt solution. In a preferred embodiment of the invention, the water-in-oil formulation according to the invention contains, in addition to the surfactant emulsifier system described above, at least one further nonionic surfactant, wherein this further surfactant has an HEB value in the range of about 8 to about 18, preferably 8 to 18, more preferably between about 10 and about 16, and even more preferably between about 11 and about 16. Preferably, the weight fraction of this additional nonionic surfactant is between 0.1 and 10 wt.%, preferably 1 to 7 wt.%, based on the W / O formulation.
[0025] Examples of second surfactants that can be used for the invention are (listed in order of brand name, HLB value, company): Arkopal N 040, 9, Clariant; Arkopal N 100, 13, Clariant; Arkopal N 150, 15, Clariant; Brij 30 POE-(4)-lauryl alcohol, 9.7, Croda; Brij 58 POE-(20)-cetyl alcohol, 15.7, Croda; Brij 76 POE-(10)-stearyl alcohol, 12.4, Croda; Brij 96V POE-(10)-oleyl alcohol, 12.4, Croda; Brij 98V POE-(20)-oleyl alcohol, 15.3, Croda; Lubrol 17A17 POE-(17)-oleyl alcohol, 14.9, Croda; Synperonic LH POE-(II)-lauryl alcohol, 15, Croda; Tween 20 POE-(20)-sorbitan monoiaurate 16.7; Tween 21 POE-(4)-sorbitan monolaurate, 13.3; Tween 40 POE-(20)-sorbitan monopalmitate, 15.6; Tween 60 POE-(20)-Sorbitanmonostearat, 14,9; Tween 65 POE-(4)-Sorbitanmonostearat, 9,6; Tween 65 POE-(20)-Sorbitantristearat, 10,5; Tween 80 POE-(20)-Sorbitanmonooleat, 15; Tween 81 POE-(5)- Sorbitanmonooleat, 10; Tween 85 POE-(20)-Sorbitantrioleat, I i ; Cremophor RH 40 Polyoxyl 40 Hydrogenated Castor Oil, 14- 16, BASF; Cremophor RH 60 PEG-60 Hydrogenated Castor Oil, 15- 17, BASF; Atlox 4913, 1 1 - 12; Emuisogen V 1816-2, 12, Clariant; Genapol V 4829 , 14, Clariant; Emuisogen V 2436, 1 1 , Clariant; Emuisogen 3510, 1 1 , Clariant.
[0026] In a further embodiment of the invention, a further (third) anionic surfactant is preferably added to the W / O formulation, particularly to fine-tune the viscosity and foaming properties of the formulation. This anionic surfactant is preferably in the form of salts with monovalent cations. The weight fraction of this further anionic surfactant is preferably between 0 and 10 wt.%, preferably 1 to 4 wt.%, based on the W / O formulation.
[0027] Niclite aqueous solvents suitable for use in the present invention are widely available and have low solubility in water. Particularly suitable non-aqueous solvents for use in the present WO formulation include aromatic hydrocarbons, such as alkylbenzenes or alkylnapthalins (e.g., SOLVESSO 100, SOLVESSO-SO 150, and SOLVESSO 200; SOLVESSO is a registered trademark; xylenes; Reutasolv DI, Reutasolv MP, Reutasolv BP 4201; Reutasolv is a registered trademark); aliphatic solvents (e.g., kerosene, Exxsol D60 and D80 from ExxonMobil); ketones (e.g., cyclohexanone or methylcyclohexanone); and alcohols (e.g., benzyl alcohol, furfuryl alcohol, or butanol). N-Alkylpyrrolidones (e.g., N-methylpyrrolidone or N-octylpyrrolidone); dimethylamides of fatty acids (e.g., Cg-Cio- fatty acid dimethylamide); vegetable and animal oils and chlorinated hydrocarbons (e.g., chlorobenzenes).
[0028] The term "vegetable oils," as used here, includes oils from all oil-producing plants, such as rapeseed oil, soybean oil, palm oil, sunflower oil, cottonseed oil, corn oil, linseed oil, coconut oil, safflower oil, or castor oil. The term "animal oil," as used here, includes oils from oil-producing animals, such as tallow. Other examples of non-aqueous solvents are the transesterification products of these oils, such as alkyl esters, for example, rapeseed oil methyl ester, such as Radia 7961 (Fina Chemicals, Belgium), or rapeseed oil ethyl ester. Vegetable oils are preferably esters of C10-C22, and preferably C2-C22, fatty acids. Such Cio-C22 fatty acid esters are, for example, esters of unsaturated or saturated Cio-C22 fatty acids, especially with an even number of carbon atoms, such as cis-erucic acid, isoerucic acid, lauric acid, palmitic acid, myristic acid, especially Cio8 fatty acids, such as stearic acid, linoleic acid or linolenic acid.Examples of Cio-C22 fatty acid esters are those esters that can be obtained by reacting glycerol or glycol with C10-C22 fatty acids and that are found, for example, in oils from oil-producing plants. as well as (Ci-C2o)alkyl(Cio-C 22)-Fatty acid esters, which can be obtained, for example, by transesterification of these glycerol or glycol Cio-C22 fatty acid esters with Ci-C20 alcohols (such as methanol, ethanol, propanol, or butanol). The transesterification can be carried out according to generally known industrial processes, which are described, for example, in Römpp's Chemistry Lexicon, 9th edition, Vol. 2, page 1343, Thieme Verlag, Stuttgart. Methyl esters, ethyl esters, n-propyl esters, isopropyl esters, n-butyl esters, isobutyl esters, n-pentyl esters, isopentyl esters, neopentyl esters, n-hexyl esters, isohexyl esters, n-heptyl esters, isoheptyl esters, n-octyl esters, 2-ethylhexyl esters, n-nonyl esters, isononyl esters, and dodecyl esters are preferred as Ci-C2O alkyl-C2O fatty acid esters. Glycerol and glycol CiO-C2O esters are also used. 22 Fatty acid esters are the monochromatic or mixed glycerol or glycol esters of C 10 - C 22-fatty acids preferred, in particular fatty acids with an even number of carbon atoms, such as cis-erucic acid, isoerucic acid, lauric acid, palmitic acid, myristic acid, in particular a Ci8 fatty acid, such as stearic acid, linoleic acid or linolenic acid.
[0029] Particularly preferred non-aqueous solvents according to the invention are dimethylamides of fatty acids (such as Genagen), vegetable oils (such as rapeseed oil methyl ester) and alkylnapthalins (such as SOLVESSO).
[0030] In a preferred embodiment, the active ingredient is soluble in the selected solvent. It can be advantageous, particularly if the active substance is not very soluble in the aforementioned solvents, to include one or more co-solvents.
[0031] According to the invention, the W / O formulation preferably comprises 5 to 75 wt.%, preferably 15 to 55 wt.% of at least one non-aqueous solvent as a component of the W / O formulation according to the invention.
[0032] Another component of the formulation according to the invention is at least one flammability salt. By means of flammability salts, carrier materials treated with the formulation according to the invention can smolder in a controlled and uniform manner after ignition and subsequent extinguishing of the flame. Thus, the flammability salt can ensure the combustibility of the treated carrier material with regard to the speed and completeness of combustion without allowing spontaneous ignition.
[0033] A fire-starting salt is preferably selected from the group of nitrate salts (e.g., potassium nitrate, chromium nitrate, iron nitrate, copper nitrate, sodium nitrate). Potassium nitrate is preferably used as the fire-starting salt.
[0034] According to the invention, the W / O formulation preferably comprises 6 to 25 wt.%, preferably 8 to 15 wt.% of at least one oxidizing salt as a component of the W / O formulation according to the invention. In the W / O formulation according to the invention, at least one insecticidal active ingredient, preferably a hydrophobic insecticidal active ingredient, is used. Preferably, hydrophobic insecticidal active ingredients are pyrethroids, bifenthrin, fipronil, a benzeneham derivative (such as hexaflumurone, teflubenzuron, flufenoxuron), an phosphate ester (such as phoxim, parathion, fenitrothion, trichlorphon, or dichlorophos), or a carbamate (such as propoxur, pirimcarb, or aldicarb). Even more preferably, an active ingredient selected from the group of pyrethroids is used as the hydrophobic insecticidal active ingredient. Furthermore, two or more insecticidal active ingredients can be provided simultaneously on the carrier material, in particular the paper carrier material, such as, for example, two, three, four, or more insecticidal active ingredients.Pyrethroide im Sinne der Erfindung sind insbesondere ausgewählt aus der Gruppe bestehend aus Acrinathrin, Allethrin, d-Allethrin, d-trans Allethrin, d-cis-trans Allethrin, Alphamethrin, Bathrin, Bifenthrin, Bioallethrin, S-Bioallethrin, Bioallethrin-S-cyclopentenyl-isomer, Bioethanomethrin, Bio- permethrin, Bioresmethrin, Clocythrin, Chlovaporthrin, Cycloprothrin, Cyfluthrin, beta-Cyfluthrin, Cyhalothrin, gamma-Cyhalothrin, lambda-Cyhalothrin, Cypermethrin, alpha-Cypermethrin, beta- Cypermethrin, cis-Cypermethrin, theta-Cypermetbrin, zeta-Cypermethrin, Cyphenotrin, Deltamethrin, Depallethrin, Empenthrin, Empenthrin (lR-isomer), Esbiothrin, Esfenvalerat, Etophenprox, Fenfluthrin, Fenpropathrin, Fenpyrithrin, Fenvalerat, Flubrocythrinate, Flucythrinat, tau-Fluvalinate, Flumethrin, Fubfenprox, Halfenprox, Imiprothrin, Kadethrin, Metofluthrin, Neopynamin, Permethrin, cis- Permethrin, Irans- ermethrin.Phenothrin, Phenothrin (1 R-trans isomer), d-Pbenothrin, Prallethrin, Profluthrin, Protrifenbute, Pynamin forte, Pyresmethrin, Pyrethrin, Resmethrin, cis-Resmethrin, R 11 15525, Silafluofen, Tau-Fluvalinate, Tefluthrin, Tetramethrin (Phthalthrin), Tetramethrin (-1 R- isomer), Terallethrin, Tralomethrin, Transfluthrin, ZXI 8901, Pyrethrins (pyrethrum) and any mixture of the aforementioned active substances.
[0035] Esbiothrin, lambda-cyhalothrin, d-allethrin, S-bioallethrin, prallethrin, metofluthrin, pyrethrum and / or transfluthrin are particularly preferred as pyrethroids. Transfluthrin is especially preferred.
[0036] According to the invention, the W / O formulation preferably comprises 0, 1 to 20 wt.%, preferably 1 to 10 wt.% of at least one insecticide as a component of the W / O formulation according to the invention.
[0037] The following compounds, for example, can be used as further insecticidal active ingredients for the formulation according to the invention:
[0038] (1) Acetylcholinesterase (AChE) inhibitors, such as carbamates, e.g. Alanycarb (II-1-1), Aldicarb (II-1-2), Bendiocarb (II-1-3), Benfuracarb (II-1-4), Butocarboxim (II-1-5), Butoxycarboxim (II-1-6), Carbaryl (II-1-7), Carbofuran (II- 1-8), Carbosulfan (II- 1-9), Ethiofencarb (II- 1- 10), Fenobucarb (II- 1 -
[0039] 1 1), Formetanate (II- 1 - 12), Furathiocarb (II- 1- 13), Isoprocarb (II- 1 -14), Methiocarb (II-1 - 15), Methomyl (II- 1-16), Metolearb (II- 1-17), Oxamyl (II- 1-18), Pirimicarb (11-1-19), Propoxur (II- 1-20), Thiodicarb (II- 1-21), Thiofanox (11-1-22), Triazamate (II- 1-23), Trimethacarb (11-1-24), XMC (11-1-25) und Xylylcarb (II- 1-26); oder Organophosphale, z.B. Acephate (II- 1-27), Azamethiphos (II- 1-28), Azinphos-ethyl (ll-l - 29), Azinphos-methyl (II- 1-30), Cadusafos (II- 1-31), Chlorethoxyfos (11-1-32), Chlorfenvinphos (11-1-33), Chlormephos (11-1-34), Chlorpyrifos (11-1-35), Chlorpyrifos-methyl (11-1-36). Coumaphos (11-1-37), Cyanophos (11-1-38), üemeton-S-methyl (11-1-39), Diazinon (11-1-40), Dichlorvos / DDVP (ll-i-41), Dicrotophos (II- 1-42), Dimethoate (11-1-43), Dimethylvinpbos (11-1-44), Disuli ton (11-1-45), EPN (ll-l- 46), Ethion (II- 1-47), Ethoprophos (II- 1-48), Famphur (II- 1-49), Fenamiphos (II- 1-50), Fenitrothion (II- 1 - 51), Fenthion (II- 1-52), Fosthiazate (II- 1-53), I lepienophos (II- 1-54), Imicyafos (II- 1-55), Isofenphos (II- 1-56),Isopropyl O-(methoxyaminothio-phosphoryl) salicylat (II- 1-57), Isoxathion (11-1-58), Malathion (II- 1-59), Mecarbam (II- 1-60), Methamidophos (11-1-61), Methidathion (11-1-62), Mevinphos (11-1-63), Monocrotophos (II- 1-64), Naled (II- 1-65), Omethoate (II- 1-66), Oxydemeton-methyl (II- 1-67), Paratliion (11-1-68), Parathion-methyl (11-1-69), Phenthoate (II- 1-70), Phorate (II- 1-71), Phosalone (II- 1-72), Phosmet (II- 1-73), Phosphamidon (II- 1-74), Phoxim (II- 1-75), Pirimiphos-methyl (II- 1-76), Profenofos (II- 1-77), Propetamphos (II- 1 -78), Prothiofos (II- 1 -79), Pyraclofos (II- 1-80), Pyridaphenthion (II- 1-81), Quinalphos (11-1-82), Sulfotep (II-1-83), Tebupirimfos (II-1-84). Temephos (II- 1-85). Terbufos (II- 1-86), Tetrachlorvinphos (II- 1-87), Thiometon (II- 1-88), Triazophos (II- 1-89), Trichlorfon (II- 1-90) und V midothion (II- 1-91).,
[0040] (2) GABA-gated chloride channel antagonists, such as cyclodiene organochlorines, e.g. chlordanes (II-2-1) and endosulfan (II-2-2); or phenylpyrazoles (fiproles), e.g. ethiproles (II-2-3) and
[0041] Fipronil (11-2-4).
[0042] (3) Sodium channel modulators / voltage-dependent sodium channel blockers, such as
[0043] Pyrethroide, z.B. Acrinathrin (II-3-1), Allethrin (II-3-2), d-cis-trans Allethrin (11-3-3), d-trans Allethrin (II- 3-4), Bifenthrin (11-3-5), Bioallethrin (11-3-6), Bioallethrin S-cyclopentenyl Isomer (II-3-7), Bioresmethrin (li-3-8). Cycloprothrin (II-3-9), Cyfluthrin (II-3-10), beta-Cyfluthrin (II-3-11), Cyhalothrin (11-3- 12), lambda-Cyhalothrin (II-3-13), gamma-Cyhalothrin (11-3-14), Cypermethrin (11-3-15), alpha-Cypermethrin (II-3-16), beta-Cypermethrin (II-3-17), theta-Cypermethrin (II-3-18), zeta-Cypermethrin (II-3-19), Cyphenothrin [(lR)-trans-Isomere] (II-3-20), Deltamethrin (II-3-21), Empenthrin [(EZ)-(lR)-Isomere) (II- 3-22), Esfenvalerate (11-3-23), Etofenprox (II-3-24), Fenpropathrin (11-3-25), Fenvalerate (11-3-26), Flucythrinate (11-3-27), Flumethrin (II-3-28).tau-Fluvalinate (11-3-29), Halfenprox (11-3-30), Imiprothrin (11-3-31), Kadethrin (11-3-32), Permethrin (11-3-33), Phenothrin [(lR)-trans isomer) (11-3-34), Prallethrin (II-3-35), Pyrethrins (pyrethrum) (II-3-36), resmethrin (II-3-37), silafluofen (II-3-38), tefluthrin (II-3-39), tetramethrin (11-3-40), tetramethrin [(1R)-isomers)] (11-3-41), tralomethrin (11-3-42) and transfluthrin (11-3-43); or DDT (11-3-44); or methoxychlor (11-3-45). (4) Nicotinergic acetylcholine receptor (nAChR) agonists, such as neonicotinoids, e.g., acetamiprid (II-4-1), clothianidin (11-4-2), dinotefuran (11-4-3), imidacloprid (II-1-4-4), nitenpyram (11-4-
[0044] 5) , thiacloprid ( 11-4-6) and thianiethoxam ( II-4-7); or nicotine ( 11-4-8 ).
[0045] (5) Nicotinic acetylcholine receptor (nAChR) allostenic activators, such as spinosins, e.g. spinetoram (Π-5-l) and spinosad (Ii-5-2).
[0046] (6) Chloride channel activators, such as avermectins / milbemycins, e.g. abamectin (II-6-1), emamectin benzoate (Π-6-2), lepimectin (II-6-3) and milbemectin (II-6-4).
[0047] (7) Juvenile hormone imitators, such as juvenile hormone analogues, e.g., hydroprene (II-7-1), kinoprene (11-7-2) and methoprene (II-7-3); or fenoxycarb (11-7-4); or pyriproxyfen (II-7-5). (8) Drugs with unknown or non-specific mechanisms of action, such as alkyl halides, e.g., methyl bromide (11-8-1) and other alkyl halides; or chloropicrin (11-8-2); or sulfuryl fluoride (II-8-3); or borax (II-8-4); or tartar emetic (II-8-5).
[0048] (9) Selective feeding inhibitors, e.g. pymetrozine (11-9-1); or flonicamide (11-9-2).
[0049] (10) Mite growth inhibitors, e.g. clofentezine (II-10-1), hexythiazox (II-10-2) and diflovidazine (II-10-3); or etoxazole (II-10-4).
[0050] (11) Microbial disruptors of the insect intestinal membrane, e.g., Bacillus thuringiensis subspecies israelensis (II-1 1-1), Bacillus sphaericus (II-11-2), Bacillus thuringiensis subspecies aizawai (II-11-3), Bacillus thuringiensis subspecies kurstaki (II-11-4), Bacillus thuringiensis subspecies tenebrioms (II-11-5) and BT plant proteins: CrylAb, CrylAc, CrylFa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, Cry34 / 35Abl (II-1 1-6). (12) Inhibitors of oxidative phosphorylation, ATP disruptors, such as diafenthiuron (II-12-1); or organotin compounds. e.g. azocyclotin (II-12-2), cyhexatine (II-12-3) and fenbutatin oxide (II-12-4); or propargite (II-12-5); or tetradifone (II-12-6).
[0051] (13) Uncouplers of oxidative phosphorylation by interrupting the H-proton gradient, such as chlorfenapyr (II-13-1), DNOC (II-13-2) and sulfuramide (II-13-3). (14) Nicotinic acetylcholine receptor antagonists, such as bensultap (II-14-1), carta-hydrochloride (II-14-2), thiocyclam (II-14-3) and thiosultap sodium (II-14-4).
[0052] (15) Inhibitors of chitin biosynthesis, type 0, such as bistrifluron (II-15-1), chlorfluazuron (II-15-2), diflubenzuron (11-15-3), flucycloxuron (II-15-4), flufenoxuron (11-15-5), hexaflumuron (11-15-
[0053] 6) , lufenuron (11-15-7), novaluron (II-15-8), noviflumuron (II-15-9), teflubenzuron (11-15-10) and triflumuron (11-15-11). (16) Type 1 inhibitors of chitin biosynthesis, such as buprofezin (11-16-1 ).
[0054] (17) Molting disruptive agents, dipterans, such as cyromazine (11-17-1).
[0055] (18) Ecdysone receptor agonists, such as chromafenozides (II-18-1), halofenozides (II-18-2), metboxyfenozides (II-18-3), and tebufenozides (II-18-4). (19) Octotopaminergic agonists, such as amitraz (II-19-1).
[0056] (20) Complex III electron transport inhibitors, such as hydramethylnon (11-20-1); or acequinocyl (11-20-2); or luaerypyrim (1-20-3).
[0057] (21) Complex I electron transport inhibitors, for example METI acaricides, e.g. fenazaquin (11-21-1), fenpyroximates (11-21-2), pyrimidifen (11-21-3), pyridaben (11-21-4), tebufenpyrad (11-21-5) and tolfenpyrad (11-21-6); or rotenone (Denis) (11-21-7).
[0058] (22) Voltage-gated sodium channel blockers, e.g. indoxacarb (11-22-1); or metaflumizone (11-22-2).
[0059] (23) Inhibitors of acetyl-CoA carboxylase, such as tetronic and tetramic acid derivatives, e.g. spirodiclofen (11-23-1), spiromesifen (11-23-2) and spirotetramai (11-23-3).
[0060] (24) Complex IV electron transport inhibitors, such as phosphines, e.g., aluminum phosphide (11-24-1), calciuric phosphide (11-24-2), phosphine (II-24-3) and zinc phosphide (II-24-4); or cyanide (11-24-
[0061] 5).
[0062] (25) Kornplex II electron transport inhibitors, such as cyenopyrafen (11-25-1).
[0063] (28) Ryanodine receptor effectors, such as diamides, e.g. chloroantraniliproles (11-28-1) and flubendiamides (11-28-2).
[0064] Other active substances with unknown mechanisms of action, such as amidoflumci (II-29-1), azadirachtin (11-29-2), benclothiaz (11-29-3), benzoximates (11-29-4), bifenazates (11-29-5), bromopropylates (11-29-6), quinomethionate (11-29-7), cryolites (11-29-8), cyantraniliprole (cyazypyr) (II-29-9), cyflumetofen (11-29-10), dicofol (11-29-11), diflovidazine (11-29-12), and fluensulfones (11-29-13).
[0065] Flufenerim (11-29-14), Flufiprole (11-29-15), Fluopyram (11-29-16), Fufenozide (11-29-17). Imidaclothiz (11-29-18), Iprodione (11-29-19). Meperfluthrin (11-29-20). Pyndalyl (11-29-21). Pyrifluqumazone (11-29-22), Tetramethyliflumrin (11-29-23) and iodomethane (11-29-24); furthermore, preparations based on Bacillus firmus (especially strain CNCM 1-1582, for example VOTiVO™, BioNem) (11-29-25) and the following known active compounds: 3-bromo-N-{2-bromo-4-chloro-6-[(l-cyclopropylethyl)carbamoyl]phenyl}-l-(3-chloropyridin-2-yl)-lFi-pyrazol-5-carboxamide (11-29-26) (known from WO2005 / 077934), 4-{[(6-bromopyrid-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one (II- 29-27) (bekannt aus WO2007 / 1 15644), 4- { [(6-Fluorpyrid-3-yl)methyl](2,2-difluorethyl)amino} furan- 2(5H)-on (11-29-28) (bekannt aus WO2007 / 1 15644), 4- {[(2-Chlor- 1 ,3-thiazol-5-yl)methyl](2- fluorethyl)amino}furan-2(5H)-on ( 11-29-29) (bekannt aus WO2007 / 1 15644), 4- {[(6-Chlorpyrid-3- yl)methyl](2-fluorethyl)amino}furan-2(5H)-on ( 11-29-30) (bekannt aus WO2007 / 1 15644), Flupyradifurone ( 11-29-3 1 ), 4- {[(6-Chlor-5-fluo^yrid-3-yl)methyl](methyl)amino} furan-2(5H)-on ( i l-29-32) (bekannt aus WO2007 / 1 15643), 4- { [(5,6-Dichlorpyrid-3 -yl)methyl](2-fluorethyl)amino} furan-2(5H)-on ( 11-29-33 ) (bekannt aus WO2007 / 1 15646), 4- {[(6-Chlor-5-fluorpyrid-3-yl)methyl](cyclopropyl)aiTiino} ftiran-2(5H)- on ( 11-29-34) (bekannt aus WO2007 / 1 15643), 4- {[(6-Chlorpyrid-3-yl)methyl](cyclopropyl)amino} iuran- 2(5H)-on ( 11-29-35 ) (bekannt aus EP-A-0 539 588), 4- {[(6-Chlorpyrid-3-yl)methyl](methyl)amino}furan- 2(5H)-on (11-29-36) (bekannt aus EP-A-0 539 588),{[l -(6-Chiorpyridin-3-yl)ethyl](methyl)oxido-, 4 - sulfanylidene} cyanamide ( 11-29-37 ) (known from WO2007 / 149134) and its diastereomers {[(lR)-l -(6- Chlorpyridin-3-yl)ethyl](methyl)oxido- 4 -sulfanylidene} cyanamide (A) (11-29-38) and {[(l S)- l -(6- Chlorpyridin-3-yl)ethyl](methyl)oxido- 4 -sulfanylidene}cyanamide (B) ( 11-29-39) (also known from WO2007 / 149134) as well as sulfoxaflor ( 11-29-40) and its diastereomers [(R)-methyl(oxido) {(lR)- l-[6- (trifluoromethyl)pyridin-3-yl]ethyl}- 4 -sulfanylidene]cyanamide (AI) ( 11-29-4 1 ) and [(S)- Methyl(oxido){(l S)- l -[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ 4 -sulfanylidene]cyanamide (A2) ( 11-29-42 ), designated as diastereomer group A (known from WO 2010 / 074747, WO 2010 / 074751), [(R)- Methyl(oxido) {(1 S)- l -[6-(trifluoromethyl)pyridin-3-yl]ethyl}- 4 -sulfanylidene]cyanamide (B 1 ) ( 11-29-43 ) and [(S)-Metbyl(oxido) {(1R)-1 - [6-(trifluoromethyl)pyridin-3 -yljethyl} -} -4-sulfanylidene]cyanamide (B2) ( II- 29-44), designated as diastereomer group B (also known from WO 2010 / 074747, WO 2010 / 074751 ) and 1 1-(4-chloro-2,6-dimethylphenyl)- 12-hydroxy- 1 ,4-dioxa-9-azadispireo [4.2.4.2]tetradec- ll-en- 10-οη ( 11-29-45 ) (known from WO2006 / 089633), 3-(4'-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-l -azaspiro[4.5]dec-3-en-2-one (11-29-46) (known from WO2008 / 06791 1), l- {2-fluoro-4-methyl-5 - [(2,2,2-trifluoroethyl)sulfinyl]phenyl} -3 -(trifluoromethyl)- 1 I I- 1,2,4-triazol-5 -amine (11-29-47) (known from WO2006 / 043635), [(3S,4aR, 12R, 12aS, 12bS)-3-[(Cyclopropylcarbonyl)oxy]-6, 12-dihydroxy- 4, 12b-dimethyl- 1 l-oxo-9-(pyridin-3-yl)-l ,3,4,4a,5,6,6a, 12, 12a, 12b-decahydro-2H, 1 II I- benzo[fjpyrano[4,3-b]chromen-4-yl]methylcyclopropanecarboxylate (11-29-48) (known from WO2008 / 066153), 2-Cyan-3-(difluoromethoxy)-N,N-dimethylbenzenesulfonamide ( 11-29-49) (known from WO2006 / 056433),2-Cyan-3-(difluoromethoxy)-N-methylbenzenesulfonamide (11-29-50) (known from WO2006 / 100288), 2-Cyan-3-(difluoromethoxy)-N-ethylbenzenesulfonamide (11-29-51) (known from WO2005 / 035486), 4-(Difluoromethoxy)-N-ethyl-N-methyl-1,2-benzothiazol-3-amine-1,1-dioxide (11-29-52) (known from WO2007 / 057407), N-[1-(2,3-dimethylphenyl)-2-(3,5-dimethylphenyl)ethyl]-4,5-dihydro-1,3-thiazol-2-amine (11-29-53) (known from WO2008 / 104503), {1 '-[(2E)-3-(4-Chlorophenyl)prop-2-en-l-yl]- 5-fluorspiro[indol-3,4'-piperidin]- 1 (2H)-yl} (2-chloropyridin-4-yl)methanone (11-29-54) (known from W02(K)3 106457), 3-(2,5-Dimethylphenyl)-4-hydroxy-8-methoxy- l,8-diazaspiro[4.5]dec-3-en-2-one (I I- 29-55) (known from WO2009 / 049851), 3-(2,5-dimethylphenyl)-8-methoxy-2-oxo- l,8-diazaspiro[4.5]dec- 3-en-4-yl-ethyl carbonate (11-29-56) (known from WO2009 / 049851), 4-(But-2-yne-l-yloxy)-6-(3,5-, dimethylpiperidin-1-yl)-5-fluoropyrimidine (11-29-57) (known from WO2004 / 099160), (2,2,3,3,4,4,5,5-octafluoropentyl)(3,3,3-trifluoropropyl)malononitrile (11-29-58) (known from WO2005 / 063094), (2,2,3,3,4,4,5,5-octafluoropentyl)(3,3,4,4,4-pentafluorobutyl)malononitrile (11-29-59) (known from WO2005 / 063094), 8-[2-(cyclopropylmethoxy)-4-(trifluoromethyl)phenoxy]
[0066] 3-yl]-3-azabicyclo[3.2.1]octan (11-29-60) (bekannt aus WO2007 / 040280), Flometoquin (11-29-61), PF1364 (CAS-Reg.Nr. 1204776-60-2) (11-29-62) (bekannt aus JP2010 / 018586), 5-[5-(3,5-Dichlorphenyl)-5- (trifluormethyl)-4,5-dihydro-l,2-oxazol-3-yl]-2-(lH-i,2,4-ljiazol-l-yl)benzonitril (11-29-63) (bekannt aus WO2007 / 075459), 5-t5-(2-ChIo!pyridiii-4-yl)-5-(iri!liu)m hyl)-4.5-dihydro- 1 ,2-oxazo!-3-yl]-2-( 1 i 1- l,2,4-triazol-l-yl)benzonitril (11-29-64) (bekannt aus WO2007 / 075459), 4-[5-(3,5-Dichlorphenyl)-5- (trifluormethyl)-4,5-dihydro-l,2-oxazol-3-yl]-2-methyl-N-{2-oxo-2-[(2,2,2- trifluorethyl)ammo]ethyl}benzamid (11-29-65) (bekannt aus WO2005 / 085216), 4-{[(6-Chlorpyridin-3- y l)methy 1] (cyclopropyl) amino} - 1 ,3-oxazol-2(5H)-on (11-29-66), 4- { [(6-Chlorpyridin-3-yl)methyl](2,2- difluorethyl)amino}-l,3-oxazol-2(5Fl)-on (11-29-67), 4-{[(6-Chlorpyridin-3-yl)methyl](ethyl)amino}-l,3- oxazol-2(5H)-on (11-29-68), 4-{[(6-CMo^yridin-3-yi)methyl](methyl)amino}-l,3-oxazol-2(5H)-on (11-29- 69) (alle bekannt aus WO2010 / 005692), NNI-0711 (H-29-70) (bekannt aus WO2002 / 096882), 1-Acetyl- N-[4-(l,l,l,3,3,3-hexafluor-2-methoxypropan-2-yl)-3-isobutylphenyl]-N-isobutyryl-3,5-dimethyl-lH- pyrazol-4-carboxamid (II-29-7!) (bekannt aus WO2002 / 096882), Methyl-2-[2-({[3-brom-l-(3- chlorpy ridin-2-yl )- ! ί l-pyrazol-5-yl ]earbonyl 'amino)-5-ehlor-3-methylbenzoyl]-2- methylhydrazincarboxylat (11-29-72) (bekannt aus WO2005 / 085216), Methyl-2- [2-( { [3 -brom- 1 -(3- chlo^yridin-2-yl)-lH-pyrazol-5-yl]carbonyl}amino)-5-cyan-3-methylbenzoyl]-2-ethylhydrazincarboxylat (11-29-73) (bekannt aus WO2005 / 085216), Methyl-2-[2-({[3-brom-l-(3-chlorpyridin-2-yl)-lH-pyrazol-5- yl]carbonyl}a]iiino)-5-cyan-3-i'nethyibenzoyi]-2-i'nethylhydrazincarboxylat (11-29-74) (bekannt aus WO2005 / 085216), Methyl-2-[3,5-dibrom-2-({[3-brom-l-(3-chlorpyridin-2-yl)-lH-pyrazol-5- yl]carbonyl}amino)benzoyl]-l,2-diethylhydrazincarboxylat (11-29-75) (bekannt aus WO2005 / 085216),Mcthyl-2-f3.5-dibrom-2-( j [3-brom- 1 -(3-chlorpyridin-2-yl)- 11 l-pyrazol-5-yI]carbonyl | amiiio)benzoyl]-2- ethylhydrazincarboxylat (11-29-76) (bekannt aus WO2005 / 085216), (5RS,7RS;5RS,7SR)-l-(6-Chlor-3- pyridylmetliyl)-l,2,3,5,6,7-hexahydro-7-methyl-8-nitro-5-propoxyimidazo[l,2-a]pyr (H-29-77) (bekannt aus WO2007 / 101369), 2-{6-[2-(5-Fluo^yridin-3-yl)-l,3-thiazol-5-yl]pyridin-2-yi}pyrimidin (II- 29-78) (bekannt aus WO2010 / 006713), 2-{6-[2-(Pyridin-3-yl)-l,3-thiazoi-5-yl]pyridin-2-yl}pyrimidin (II- 29-79) (bekannt aus WO2010 / 006713), l-(3-Chlorpyridin-2-yl)-N-[4-cyan-2-methyl-6- (methylcarbamoyl)phenyl]-3- { [5 -(trifluormethyl)- 1 H-tetrazol- 1 -yljmethyl} - 1 H-pyrazol-5 -carboxamid (II- 29-80) (bekannt aus WO2010 / 069502), l-(3-Chloipyridin-2-yl)-N-[4-eyan-2-mcihyl-6- (meihylcarbamoyl)phenyl]-3- ! [5-(irinuormcthyl)-2l l-le!razol-2-yl)melhyl! -11 l-py!azol-5-carboxamid (II- 29-81) (bekannt aus WO2010 / 069502),N-[2-(tert-Butylcarbamoyl)-4-cyan-6-methylphenyl]-l-(3- chlorpyridin-2-yl)-3- { [5 -(trifluormethyl)- 1 H-tetrazol- 1 -yljmethyl} - 1 H-pyrazol-5-carboxamid (11-29-82) (bekannt aus WO2010 / 069502), N- [2-(tert-Butylcarbamoyl)-4-cyan-6-methylphenyl]- 1 -(3 -chlorpyridin-2- yl)-3-{[5-(trifluormethyl)-2H-tetrazol-2-yl]methyi}-lH-pyrazol-5-carboxamid (11-29-83) (bekannt aus, WO2010 / 069502), ( 1 E)-N- [(6-CMo^yridin-3-yl)methyl]-N'-cyan-N 2,2-difluorethyl)ethanimidamid ( II- 29-84) (bekannt aus WO2008 / 009360), N-[2-(5-Amino-l,3,4-thiadiazoi-2-yl)-4-chlor-6-methylphenyl]-3- brom-l-(3-chlorpyridin-2-yl)-lH-pyrazol-5-carboxainid (11-29-85) (bekannt aus CN102057925) und eihyl-2-[3.5-dibrom-2-( -| [3-brom- 1 -(3-ehlorpyridin-2-yl)- 11 l-pyrazol-5-yl]carbonyl | amino)benzoyl ]-2- ethyl- 1 -methylhydrazincarboxylat (11-29-86) (bekannt aus WO201 1 / 049233).
[0067] The active ingredients mentioned here by their "common name" are known and are described, for example, in the Pesticide Manual ("The Pesticide Manual" 14th Ed., British Crop Protection Council 2006) or can be researched on the Internet (e.g. http: / / www.alanwood.net / pesticides).
[0068] The present WO formulation also contains water. The W / O formulation according to the invention preferably comprises 20 to 85 wt.%, more preferably 35 to 60 wt.% water.
[0069] In a preferred embodiment of the present invention, the W / O formulation according to the invention preferably further comprises at least one dye and / or at least one fragrance. Preferably, the formulation according to the invention comprises at least one dye and at least one fragrance.
[0070] Inorganic pigments, e.g., iron oxide, titanium dioxide, ferrocyanine blue, and organic pigments and dyes, such as triphenylmethanes, diphenylmethanes, oxazines, xanthenes, imininonaphthoquinones, azomethines, and anthraquinones, such as Oil Yellow #101, Oil Yellow #103, Oil Pink #312, Oil Red, Oil Green BG, Oil Blue BOS, Oil Blue #603, Oil Black BY, Oil Black BS, Oil Black To 05 (Orient Kagaku Kogyo), Victoria Pure Blue Bül t (llodogaya Kagaku), and Patent Pure Blue (Sumitomo Mikuni Kagaku), can be used as colorants.Crystal Violet (CI 4255), Methyl Violet (CI 42535), Ethyl Violet, Rhodamine B (CI 14 17013), Malchite Green (CI 142000), Methylene Blue (CI 52015), Brilliant Blue, Methyl Green, Erythrocin B, Basic Fuchsine, m-Cresol Purple, Auramine, 4-p-Diethylaminophenyliminaphthoquinone, Leucobasis dyes and primary or secondary acrylamine dyes, such as Triphenylamine, Diphenylamine, o-Chloroaniline, 1,23,-Triphenylganidine, Naphthylamine, Diaminodiphenylmethane, ρ,ρ-Bis-dimethylaminodiphenylamine, 1,2-Danilinoethylene, p,p. , ,p"-tris-Dimethylaminotriphenylmethane, p.p'-Bis- dimethylaminodiphenylmethylimine, p,p,p"-Triamino-o-methyltriphenylmethane, p.p'-Bis- dimethylaminodiphenyl-4-anilinonaphthylmethane, ρ,ρ',ρ''-Triaminotriphenylmethane, etc., are used.
[0071] Anionic, cationic, or basic dyes are preferred, such as xanthene dyes like Ceravon Fast Rhodamine B 400% (DixonChew) and Sanolin Rhodamine B02 (Clariant).
[0072] Direct dye Levacell Violet BB l. 40% (Lanxess), the azo dye Bayscript Magenta LB fl. (Lanxess), Ceracryl Magenta (DixonChew), Astra Red Violet 3RC liq. (Lanxess), Astra Phloxin G (Lanxess) and Cartazine Violet 4EK liq. (Clariant) were used.
[0073] Anionic dyes are particularly preferred, such as the xanthene dyes Ceravon Fast Rhodamine B 400% (DixonChew) and Sanol in Rhodamine B02 (Clariant), the direct dye Levacell Violett BB fl. 40% (Lanxess) and the azo dye Bayscript Magenta LB fl. (Lanxess).
[0074] Depending on the solubility of the dyes, further surfactants are used according to the invention to dissolve the dyes. For example, when using triaminotriphenylmethane, the dye is dissolved with water and a surfactant, preferably at elevated temperatures (up to 70°C), before being added to the formulation according to the invention. A suitable surfactant is, for example, a non-ionic surfactant made from ethoxylated alcohol (as described above).
[0075] Natural fragrances can be selected, for example, from the group consisting of lavender, musk, civet, ambergris, castor oil and similar fragrances: ajowa oil, almond oil. Ambrette seed absolute, angelica root oil, anisole, basil oil, bay laurel oil, benzoin resinoid, bergamot essence, birch oil, rosewood oil, needlewort absolute, cajeput oil, cananga oil, gapmiscum oil, cumin oil, cardamom oil, carrot seed oil, cassia oil, cedarwood oil, celery seed oil, cinnamon bark oil, citronella oil, clary sage oil, clove oil, cognac oil, coriander oil, cubeb oil, camphor oil, dill oil, tarragon oil, eucalyptus oil, sweet fennel oil, calbanum resinoid, garlic oil, geranium oil, ginger oil, grapefruit oil, hop oil, hyacinth absolute, jasmine absolute, juniper berry oil, labdanum resinoid, lavender oil, bay leaf oil, lemon oil, lemongrass oil, lovage oil, mace oil Mandarin oil. Narcissus absolute, Myrrh absolute, Sulfate. Narcissus absolute, Neroli oil, Nutmeg oil, Oakmoss absolute.Olibanum resinoid, onion oil, opoponax resinoid, orange oil, orange blossom oil, iris concrete, pepper oil, peppermint oil, Peruvian balsam, petitgrain oil, pine needle oil, rose absolute, rose oil, rosemary oil, sandalwood oil, sage oil, spearmint oil, styrax oil, thyme oil, tolu balsam, tonka bean absolute, tuberose absolute, turpentine oil, vanilla bean absolute, vetiver oil, violet leaf absolute, ylang-ylang oil and similar plant oils, etc., and their mixtures.
[0076] The following synthetic fragrances can be added to the formulation according to the invention: pinene, limonene and similar hydrocarbons, 3,3,5-trimethyl cyclohexanol, linalool, geraniol, nerol, citronellol, menthol, borneol, borneylethoxycyclohexanol, benzyl alcohol, anise alcohol, cinnamyl alcohol, β-phenylethyl alcohol, cis-3-hexanol, terpineol and similar alcohols; anethole, musk xylene.
[0077] Isoeugenol, methyleugenol and similar phenols; amyl cinnamaldehyde, anisaldehyde, n-butyraldehyde, cuminaldehyde, cyclamenaldehyde, decyl aldehyde, isobutyraldehyde, hexyl aldehyde, heptyl aldehyde, n-nonyl aldehyde nonadienol, citral, citronellal, hydroxycitronellal, benzaldehyde, methyl nonyl acetaldehyde, cinnamaldehyde, dodecanol, hexyl cinnamaldehyde, undecanal, heliotropin Vanillin, ethyl vanillin and similar aldehydes, methyl amyl ketone, methyl β-naphthyl ketone, methyl nonyl ketone, musk ketone, diacetyl, acetyl propionyl, acetyl butyryl, carvone, methone, camphor, acetophenone, p-methylacetophenone, ionone, methyl ionone and similar ketones; Amyl butyrolactone, diphenyl oxide, methyl phenyl glycidate, nonylacetone, coumarin, cineole, ethyl methyl phenyl glycidate and similar lactones or oxides, methyl formate, isopropyl formate, linalyl forniate, ethyl acetate, octyl acetate, methyl acetate, benzyl acetate, cinnamyl acetate, butyl propionate, isoamyl acetate, isopropyl isobutyrate, Gerany isovalerate, allyleapronate butyl heptylate, octyl caprylate, methyl heptine carboxylate, methyl octyne carboxylate, isoamyl caprylate, methyl laurate, ethyl myristate, methyl myristate, ethyl benzoate, benzyl benzoate, methyl carbinyl phenyl acetate, isobutyl phenyl acetate, methyl innamate, styracine, methyl salicylate, Ethyl anisate, methyl anthranilate, ethyl pyruvate, ethyl butyl butyrate, benzyl propionate, butyl acetate, butyl butyrate, p-tert.-Butylcyclohexyl acetate, cedryl acetate, citronellyl acetate, citronellyl formate, p-cresyl acetate, ethyl butyrate, ethyl caproate, ethyl cinnamate, ethyl phenyl acetate, ethylene brassylate, geranyl acetate, geranyl formate, isoamyl salicylate, isoarnyl valerate, isobomyl acetate, linalyl acetate, methyl anthranilate, methyl ethyl acetate, nonyl acetate, β-phenylethyl acetate, trichloromethylenephenyl carbinyl acetate, terpinyl acetate, vetiveryl acetate, and similar esters. These fragrances can be used individually, or at least two of them can be used together in a mixture. In addition to the fragrance, the formulation according to the invention may optionally contain additives commonly used in the fragrance industry, such as patchouli oil or similar volatile inhibitors, such as eugenol, or similar viscosity-regulating agents.
[0078] The formulations according to the invention can also contain deodorizing agents, such as lauryl methacrylate, geranyl crotonate, acetophenone myristate, p-methylacetophenone benzaldehyde, benzyl acetate, benzyl propionate, amyl cinnamaldehyde, anisaldehyde, diphenyl oxide, methyl benzoate, ethyl benzoate, methylphenyl acetate, ethylphenyl acetate, Neolin, Sa-free, etc. Preferably, the fragrances are already a component of the non-aqueous solvent.
[0079] In general, the W / O formulation preferably comprises 1 to 75 wt.%, more preferably 2 to 55 wt.% of a fragrance substance, and more preferably 5 to 15 wt.%.
[0080] In a further preferred embodiment of the invention, the W / O formulation preferably comprises 0.01 to 5 wt.%, more preferably 0.01 to 1 wt.% of a dye. The total wt. percentage of the components described above relating to the W / O formulation does not exceed 100%.
[0081] Optionally, the W / O formulation according to the invention further comprises additives or auxiliaries, preferably antifreeze agents, bittering agents, stabilizers, antifoaming agents, wetting agents, defoamers, and preservatives. Examples of suitable antifreeze agents are ethylene glycol, Monopropylene glycol, glycerin, hexylene glycol, 1-methoxy-2-propanol, cyclohexanol, especially monopropylene glycol. Suitable bittering agents include, in particular, flavoring oils, preferably peppermint oil, eucalyptus oil, bitter almond oil, menthol, fruit flavorings, preferably flavorings of lemons, oranges, limes, grapefruit, or mixtures thereof, and / or denatonium benzoate. Stabilizers that may be added to the formulation are acids, preferably organic acids such as dodecylbenzenesulfonic acid, acetic acid, propionic acid, or citric acid, especially citric acid, and antioxidants such as butylhydroxytoluene (BHT), butylhydroxyanisole (BIA), especially butylhydroxytoluene.Preferred antifoaming agents and defoamers are silicone-based, particularly preferred being an aqueous emulsion of dialkylpolysiloxanes, commercially available as Rhodorsil®; 426R from Rhodia Chimie France, Wacker SE series from Wacker, Germany, and a mixture of dialkylpolysiloxanes as an oil, commercially available as Rhodorsil®; 416 from Rhodia Chimie, France, Wacker 5184 or Wacker SL from Wacker, Germany.
[0082] Optionally, the formulations according to the invention also contain further functional additives that influence the combustion properties or other characteristics of the carrier materials treated with the formulation according to the invention. Examples of such additives include phosphate salts (such as sodium phosphates, monoammonium phosphates), organic acids (such as trisodium citrate, tripotassium citrate, sodium acetate, sodium tartrate, succinic acid, malonic acid, etc.), and waxes. Further examples of such additives are mineral inorganic substances such as titanium dioxide, calcium carbonate, layered silicates such as kaolin, and organic fillers such as microcrystalline cellulose.
[0083] Another aspect of the invention relates to the use of a formulation according to the invention for treating a carrier material.
[0084] According to the invention, "treatment" refers to a process in which a carrier material is brought into contact with the formulation. Suitable treatment methods include impregnation, for example, by spraying the carrier material with the formulation according to the invention and subsequent drying, e.g., in air, or by immersing the carrier material in the formulation according to the invention and subsequent drying, e.g., in air. Other suitable impregnation methods include impregnation using a pipette. Printing the carrier material with the formulation according to the invention is a particularly suitable and preferred treatment method.
[0085] For printing the formulation onto the substrate, established application methods or coating systems for continuous operation are preferably used. Suitable printing methods and corresponding systems are known, for example, from the graphic arts industry (direct printing). and indirect printing processes) as well as from the paper industry (coating and impregnation methods). Other well-known equipment / methods include the doctor blade press, the film press, the size press, curtain coating, and others.
[0086] Gravure printing methods are particularly preferred, in which the transfer of the formulation according to the invention takes place directly from the rotating gravure printing roller to the substrate material.
[0087] It has been shown that the present formulation is particularly suitable for homogeneous application to a substrate using a gravure printing method. The formulation according to the invention remains physically stable and can be easily adapted to the selected gravure printing method with regard to its rheological properties (in particular viscosity and wetting properties). Within the scope of the present invention, the term "physically stable" means that, on a relevant timescale for the application of the formulation in the one-step coating process, particularly using a gravure printing method, no significant or macroscopic phase separation of the water and oil phases or creaming occurs.
[0088] Adjusting the viscosity of the formulation to the coating method may be necessary to avoid undesirable process-related side effects (such as inhomogeneous film splitting and mist formation, which can lead to inhomogeneities in the coating). Viscosity properties are preferably controlled by changing the weight fractions of the surfactant emulsifier and / or by changing the composition of the surfactant emulsifier and / or by changing the proportions of the aqueous phase to the continuous "oil phase".
[0089] It has been shown that when using a conventional gravure printing method and the preferred paper support material defined below, a Bingham viscosity of the W / O formulation according to the invention of between 20 and 200, preferably 30 to 150 as at 20°C is advantageous.
[0090] The determination of Bingham viscosity is based on the measurement of shear stress with increasing viscosity.
[0091] -1
[0092] Shear rate. The resulting shear stress values [Pa] are plotted against the shear rate [s]. The Bingham viscosity is derived at higher shear rates as the slope of the regression line.
[0093] Viscosity measurement is performed at a temperature of 20°C using a rotational viscometer with cylinder-type measuring systems (also double-gap systems) standardized according to DIN EN ISO 321 and a defined, adjustable shear rate, e.g., from the companies Flaake, Bohlin, Mettler, Contraves, and
[0094] -1 other. The viscometer should allow measurements in a shear rate range of 0.1 to 1200 s. An advantage of the W / O formulations according to the invention is that the Bingham viscosity can be adjusted without the use of polymeric thickeners, thus ensuring very good and homogeneous transfer of the formulation from the gravure roller to the substrate, even at increased production speeds. Upon drying, formulation residues – unlike formulations with polymeric thickeners – can be easily removed from the gravure roller with water or with conventional aqueous cleaning agents.
[0095] According to the invention, suitable carrier materials include, in particular, solid combustible materials such as cellulose materials, textile materials, plastic materials, etc. Cellulose-based carrier materials include, for example, paper, cardboard, wood, wood chips, wood shavings or sawdust, rice husks, corn cobs (preferably without kernels), pecan shells, and peanut shells. Thin particleboard is also suitable as a carrier material. A corresponding cellulose-based carrier is described, for example, in German patent application DE 43 223 76 AI, the disclosure of which is incorporated by reference into the present application.
[0096] Textile backing materials include synthetic fibers such as polyester or nylon, or natural fibers like cotton, viscose, a linen-viscose blend, or a mixture of synthetic and natural fibers such as cellulose-polyester (synthetic paper) or cotton-polyester. Other examples are wool felt and Trevira satin.
[0097] Examples of plastic carrier materials include polycarbonates, polyesters, polyamides, and polyterephthalates. Within the scope of the present invention, the use of a cellulose-based carrier material, particularly a paper carrier, is especially preferred.
[0098] In principle, the paper carrier used is not subject to any special restrictions, as long as it is generally suitable to absorb at least one corresponding insecticidal active ingredient and, after ignition and extinguishing of the paper carrier, to release the at least one insecticidal active ingredient without substantially decomposing it.
[0099] However, it has turned out that paper carriers with a paper weight of preferably 25 to 300 g / m² 2 , especially 25 to 270 g / m² 2 , particularly preferably 25 to 250 g / m² 2 , especially preferred 25 to 230 g / m² 2 , especially preferred 25 to 215 g / m² 2 , specifically 25 to 200 g / m² 2, are particularly suitable for the purpose according to the invention. Furthermore, it is preferred if the thickness of the paper carrier is in the range of 0.05 to 0.50 mm, particularly preferably 0.07 to 0.40 mm, most preferably 0.08 to 0.35 mm, and more preferably between 0.08 and 0.25 mm, specifically 0.08 to 0.20 mm. Suitable carrier materials and methods for treating the carrier materials are also described in the patent application WO2007 / 131679A2.
[0100] A further aspect of the present invention relates to the use of the water-in-oil formulation according to the invention for treating a substrate material. Preferably, the "treatment" is carried out by printing on the substrate material. Even more preferably, the substrate material is printed using a gravure printing process, preferably a "one-step" printing process.
[0101] Another aspect of the present invention relates to a carrier material treated with a water-in-oil formulation according to the invention. It is preferred that the application weight of the (W / O) formulation on the carrier (preferably the paper carrier) is in the range of 5 to 30 ml / m². 2 , particularly preferably from 12 to 22 ml / m³ 2 and especially preferred at 15 to 20 ml / m² 2 lies.
[0102] The content of insecticidal active ingredient on a carrier material according to the invention, in particular a paper carrier, is preferably between 0.05 and 5.0 wt.%, more preferably between 0.1 and 2.5 wt.% and even more preferably between 0.2 and 1.5 wt.%.
[0103] It is preferred if the oxidizing salt content of the treated carrier material (preferably a paper carrier) is in the range of 0.1 to 6 wt.%, particularly preferably from 1 to 5 wt.% and most preferably from 1.5 to 3 wt.%.
[0104] In general, the carrier material according to the invention (in particular a paper carrier) preferably comprises 0.01 to 10 wt.%, more preferably 0.05 to 5 wt.%, and most preferably 0.1 to 2 wt.%, at least one surface-active emulsifier system described above.
[0105] It is preferred that the treated carrier material contains a fragrance which positively influences the odor of the smoldering end product before and after combustion.
[0106] It is preferred if the fragrance content of the treated carrier material (preferably a paper carrier) is in the range of 0.1 to 10 wt.%, particularly preferably from 0.5 to 5 wt.% and most preferably from 1.0 to 3 wt.%.
[0107] In a preferred embodiment of the invention, the carrier material according to the invention (preferably a paper carrier) contains, in addition to the surface-active emulsifier system described above, at least one further non-ionic surface-active agent, wherein this further surface-active agent has an HLB value in the range of approximately 8 to approximately 18, preferably 8 to 18, more preferably between approximately 10 and approximately 16, more preferably 10 to 16. preferably between about 1 and about 16, more preferably between 1 and 16. Preferably, the weight fraction of this further nonionic surfactant is between 0.1 and 4 wt.%, more preferably 0.3 and 1.5 wt.%, based on the carrier material according to the invention.
[0108] In a further preferred embodiment of the invention, the carrier material according to the invention (preferably a paper carrier) contains a further (third) anionic surfactant. Preferably, the weight fraction of this further anionic surfactant is between 0 and 5 wt.%, more preferably 0.1 to 2.5 wt.%, based on the carrier material according to the invention. The remaining weight percentages, which add up to a maximum of 100%, relate to the carrier material (preferably a paper carrier) itself.
[0109] A further object of the invention relates to a method for producing the water-in-oil formulation according to the invention, comprising the following steps: a) dissolving at least one fire salt in water, b) dissolving at least one insecticidal active ingredient and at least one emulsifying system, which has a solubility of less than lg / L in a 16% potassium nitrate salt solution, in at least one non-aqueous solvent, c) mixing the solution according to step b) with the solution from step a).
[0110] If optionally further water-soluble formulation components (such as cationic or anionic dyes, other additives) are to become part of the W / O formulation, these are added to the water at the same time as the slag salt in step a).
[0111] If optionally further water-insoluble liquid formulation components (such as fragrances, other additives) are to become part of the W / O formulation, then these are mixed into the non-aqueous solvent before step b).
[0112] The mixing to a W / O formulation according to the invention in step c) is carried out by homogenization via simple stirring or via a conventional emulsifying process.
[0113] A further object of the present invention relates to an insecticidal, smoldering product comprising a carrier material as described above and the components of the water-in-oil formulation as described above, wherein the non-aqueous solvent can evaporate from the carrier material during production (e.g. during a drying step downstream of production or later). A further aspect of the invention is a method for producing an insecticidal, smoldering product, characterized in that a carrier material is treated with a water-in-oil formulation according to the invention. Preferably, the production is carried out by printing the carrier material with the water-in-oil formulation according to the invention. Even more preferably, the carrier material is printed using an intaglio printing process, preferably a one-step printing process.
[0114] Examples:
[0115] Example 1: Description of the production of the formulations according to the invention
[0116] The following formulations according to the invention (Fl A = formulation A according to the invention; Fl B = formulation B according to the invention; Fl C = formulation C not according to the invention for comparison) were prepared with transfluthnn according to the manufacturing instructions given above (see page 21):
[0118] Table 1: List of formulation components in weight percentages based on the respective W / O formulations according to the invention. (Fl A ~ Formulation A according to the invention; Fl B = formulation B according to the invention).
[0119] For comparison, the following non-inventive formulation with transfluthrin was also prepared according to the same manufacturing procedure mentioned above:
[0120] Table 2: Non-inventive formulation C (Fl C) for comparison.
[0121] The mixing of the formulations according to manufacturing step c) (see p. 21) was carried out by simple stirring using a conventional magnetic stirrer.
[0122] The specific conductivity was characterized using a Knick laboratory instrument (Portamess® 91 1 Cond in combination with conductivity sensor SE 204). The Bingham viscosity of the homogenized formulations was determined using a Haake rheometer (Haake RS-150, sensor Z20 Din Ti) at 20°C. The results of both investigations are shown in Table 3 below:
[0124] Table 3: Bingham viscosity and specific conductivity of the formulations prepared according to Example 1.
[0125] Example 2: Description of the production of the insecticide according to the invention, smoldering product
[0126] To produce the insecticidal papers, the active ingredient formulations described in Example 1 (Fl A, Fl B, and Fl C as controls) were applied to the substrate using a gravure printing process with a defined application weight, ensuring a full and homogeneous coverage. The substrate used was Tauro Offset 90 gsm offset paper (Robert Horn Group). The formulations were applied in a single step using the PhantomQD™ Proofer (HARPER Graphics GmbH) and the 306 140 100 20.0C anilox roller (theoretical build volume approx. 31 cm³). 3 / m 2 and a 60-degree engraving angle (HARPER Graphics GmbH). The formulation was applied with constant pressure and an application weight of approximately 16 g / m². 2The design was transferred directly from the gravure printing roller to a paper strip. The printed paper strips were dried in ambient air for at least one hour and then checked for print quality (via visual assessment of the paper ink homogeneity) and smoldering behavior. Smoldering behavior was tested by folding the coated paper strips lengthwise, lighting one side, blowing out the resulting flame, and placing the strip on a fireproof surface to burn completely. The complete smoldering or burning of the paper strip is considered a measure of the coated paper strip's smoldering behavior. Insecticidal, smoldering
[0127] product
[0128] applied formulation Fl A Fl B Fl C
[0129] Order weight (g / m 2 ) 16 16 16
[0130] Coating quality homogeneous homogeneous inhomogeneous
[0131] Glowing behavior completely completely not completely
[0132] Table 4: Coating quality and smoldering behavior of the insecticides and smoldering products produced according to Example 2.
[0133] Figure 1 shows the coating quality of the insecticides and smoldering products produced according to Example 2 (applied formulations from left to right: Fl A, Fl B, and Fl C). While Fl A and Fl B exhibit a homogeneous coating, Fl C shows an inhomogeneous coating.
[0134] Example 3: Description of the production of a fragrance-free formulation according to the invention and
[0135] Insecticides, smoldering product Analogous to Example 1, the following formulation according to the invention D (FL D) without fragrance with transfluthrin was prepared according to the manufacturing procedure given above (see page 21).
[0137] Analogous to Example 2, formulation D was used to produce an insecticidal paper. The formulations were applied in a single step using the PhantomQD™ Proofer (HARPER Graphics GmbH) and the 306 140 100 20.0C anilox roller (theoretical build volume approx. 31 cm³). 3 / m 2 and a 60-degree engraving angle (HARPER Graphics GmbH) onto Tauro Offset 90 gsm offset paper (Robert Horn Group). The W / O formulation with a specific conductivity < 0.1 mS / cm was applied with constant pressure and an effective coating weight of approximately 16 g / m². 2 transferred directly from the gravure printing roller onto a strip of paper. After After subsequent drying in the room air, a homogeneously colored insecticidal paper was obtained. The insecticidal paper completely burned away.
Claims
A water-in-oil formulation comprising a) at least one surfactant emulsifying system which has a solubility of less than 1g / L in a 16% potassium nitrate salt solution, b) at least one non-aqueous solvent, c) at least one fire salt, d) at least one insecticidal active ingredient, and e) water. A water-in-oil formulation according to claim 1, wherein at least one surfactant emulsifying system is a non-ionic surfactant with a 1 II. - Werl in the range of about 2 to about 10 or an ionic surfactant as a salt with monovalent or polyvalent cations is used as the emulsifying system. A water-in-oil formulation according to claim 2, characterized in that the emulsifying system is selected from the group consisting of: alkylphenol ethoxylates, alkanol ethoxylates, alkylamine ethoxylates, sorbitan esters and their ethoxylates, castor oil ethoxylates, ethylene oxide / propylene oxide block copolymers, Alkanol / propylene oxide / ethylene oxide copolymers, polyglycerols, polyglycerol esters or the emulsifying system is selected from the group consisting of: alkyl sulfonates, aryl sulfonates, alkyl aryl sulfonates, aryl ether sulfonates, lignosulfonates, alkyl sulfates, alkyl ether sulfates, sulfosuccinates, aliphatic and aromatic phosphate esters, alkoxylated phosphate esters, alkyl carboxylates and polycarboxylates; each as salts of multivalent cations. A water-in-oil formulation according to one of the preceding claims, characterized in that at least one further non-ionic surfactant is present, wherein this surfactant has a I II B value in the range of about 8 to about 18.
5. A water-in-oil formulation according to one of the preceding claims, characterized in that the insecticidal active ingredient is a pyrethroid.
6. A water-in-oil formulation according to one of the preceding claims, characterized in that the oxidizing salt is potassium nitrate.
7. A water-in-oil formulation according to one of the preceding claims, characterized in that the formulation further contains at least one dye and / or at least one fragrance.
8. Use of a water-in-oil formulation according to any of the preceding claims for treating a carrier material.
9. Carrier material treated with a water-in-oil formulation according to any one of claims 1 to 7.
10. Carrier material according to claim 9, characterized in that the carrier material is a paper carrier.
1. Method for producing the water-in-oil formulation according to the invention comprising the following steps: a) dissolving at least one fire salt in water, b) dissolving at least one insecticidal active ingredient and at least one emulsifying system, which has a solubility of less than lg / L in a 16% potassium nitrate salt solution, in at least one non-aqueous solvent, c) mixing the solution according to step b) with the solution from step a).
12. Insecticidal, smoldering product comprising a) a carrier material, b) at least one emulsifying system, each of which has a solubility of less than lg / L in a 16% potassium nitrate salt solution, c) at least one fire salt, d) at least one insecticidal active ingredient, and e) water.
13. Method for producing a carrier material according to claim 9, 10 or an insecticidal, smoldering product according to 12, characterized in that a carrier material is treated with a water-in-oil formulation according to one of claims 1 to 7.
14. Method according to claim 13, characterized in that the carrier material is printed with a water-in-oil formulation according to one of claims 1 to 7.
15. Method according to claim 14, characterized in that the carrier material is printed with a water-in-oil formulation according to one of claims 1 to 7 using an intaglio printing method in a one-step process.
